Oregon Department of Corrections
Approved Formulary
Search by name
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
February P&T meeting minutes have been posted.
Oregon Department of Corrections
Approved Formulary
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Hazardous Drugs
In-Cell HD
Earned In-Cell
Formulary Duration Restrictions
Therapeutic Substitutions
Webpage Links
Search results for:
drospirenone-ethinyl estradiol
drospirenone-ethinyl estradiol
Hazardous Drugs
Handling Guide (Group 2: Non-Antineoplastic)
Cell Status
In-Cell HD
Exceptions / Designators
Formulary restricted to only the ethinyl estradiol 20 mcg and drospirenone 3 mg formulation.
Brand names:
GIANVI, JASMIEL, LORYNA, NIKKI, YAZ
Form
Strength
TABLET, ORAL
3 mg-20 mcg
Additional Information:
MAY 2022 P&T MINUTES
Last updated:
Nov. 16, 2023
In-Cell HD
UpToDate
Micromedex
Pharmacist's Letter
FDA DailyMed Package Insert
WebMD Pill Identifier
MAY 2022 P&T MINUTES